Cardeon Corp.
This article was originally published in Start Up
Executive Summary
The only known cerebro-protectant that has been shown to reduce the severity of stroke and ischemia is cold. Cardeon is therefore developing devices based on the principle of hypothermia to protect the brain against damage during or after cardiovascular and other surgical procedures. The company's technology also segments the brain circulation from the corporeal circulation to keep the brain free of emboli.